Prevalence of metabolic syndrome diagnosis in patients with obstructive sleep apnoea syndrome according to adopted definition;Częstość rozpoznawania zespołu metabolicznego u chorych na obturacyjny bezdech senny w zależności od zastosowanej definicji

Pneumonologia i Alergologia Polska

Volumn 81, Issue 5, 2013, Pages 417-423

  Kumor, Marta ^a   Bielicki, Piotr ^a   Barnaś, Małgorzata ^a   Przybyłowski, Tadeusz ^a   Zieliński, Jan ^a   Chazan, Ryszarda ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Definition; Metabolic syndrome; Obstructive sleep apnoea

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; BODY MASS; COMORBIDITY; FEMALE; HEALTH STATUS; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTOR; SLEEP APNEA, OBSTRUCTIVE; WAIST CIRCUMFERENCE;

ADULT; AGE DISTRIBUTION; AGED; BODY MASS INDEX; COMORBIDITY; FEMALE; HEALTH STATUS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; WAIST CIRCUMFERENCE;

EID: 84883475407     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Pacholczyk M., Ferenc T., Kowalski J. Zespół metaboliczny. Cze{ogonek}ść I: Definicje i kryteria rozpoznawania zespołu metabolicznego. Epidemiologia oraz zwia{ogonek}zek z ryzykiem chorób sercowo-naczyniowych i cukrzycy typu2. Poste{ogonek}py Hig. Med. Dośw. 2008; 62: 530-542.
2. Grundy S.M. Does a diagnosis of metabolic syndrome have value in clinical practice? Am. J. Clin. Nutr. 2006; 83: 1248-1251.
3. ATP III Final Report. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002; 106: 3143-3421.
4. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 2006; 23: 469-480.
5. Grundy S.M., Cleeman J.I., Daniels S.R. i wsp. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.; American Heart Association; National Heart, Lung, and Blood Institute. Circulation 2005; 112: 2735-2752.
6. Alberti K.G., Eckel R.H., Grundy S.M. i wsp. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
7. Wilcox I., McNamara S.G., Collins F.L. i wsp. Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 1998;53 (supl.): 25-28.
8. Gruber A., Horeood F., Sithole J. i wsp. Obstructive sleep apnea is independently associated with metabolic syndrome but not insulin resistance state. Cardiovascular Diabetol. 2006; 1: 5-22.
9. Coughlin S.R., Mawdsley L., Mugarza J.A. Obstructive sleep apnea is independently associated with an increased prevalence of metabolic syndrome. Eur. Heart J. 2004; 25: 735-741.
10. Levy P., Bonsignore M.R., Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur. Respir. J. 2009; 34: 243-260.
11. Lam J.C.M., Lam B., Lam C.-L. i wsp. Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in HongKong. Respir. Med. 2006; 100: 980-987.
12. Sasanabe R., Banno K., Otake K. i wsp. Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome. Hypertens. Res. 2006; 29: 315-322.
13. Peled N., Kassirer M., Shitrit D. i wsp. The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir. Med. 2007; 101: 1696-1701.
14. Shiina K., Tomiyama H., Takata Y. i wsp. Concurrent presence of metabolic syndrome in obstructive sleep apnea syndrome exacerbates the cardiovascular risk: a sleep clinic cohort study. Hypertens. Res. 2006; 29: 433-444.
15. Tkacova R., Dorkova Z., Molcanyiova A. i wsp. Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea. Med. Sci. Monit. 2008; 14: CR438-CR444.
16. Robichaud-Hallé L., Beaudry M., Fortin M. Obstructive sleep apnea and multimorbidity. BMC Pulm. Med. 2012; 12: 60.
17. Vgontzas A.N., Bixler E.O. i Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med. Rev. 2005; 9: 211-224.
18. Nock N.L., Li L., Larkin E.K., Patel S.R., Redline S. Empirical evidence for "syndrome Z": a hierarchical 5-factor model of the metabolic syndrome incorporating sleep disturbance measures. Sleep 2009; 32: 615-622.
19. Wahrenberg H., Hertel K., Leijonhufvud B.M. i wsp. Use of waist circumference to predict insulin resistance: retrospective study. BMJ 2005; 330: 1363-1364.
20. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Geneva: World Health Organization, 2000.
21. st ed. Westchester, IL: American Academy of Sleep Medicine, 2007.
22. Zdrojewski T., Bandosz P., Szpakowski P. i wsp. Rozpowszechnienie głównych czynników ryzyka chorób układu sercowo-naczyniowego w Polsce. Wyniki badania NATPOL PLUS. Kardiol. Pol. 2004; 61(supl. IV): IV1-IV26.
23. Wyrzykowski B., Zdrojewski T., Syganowska E. i wsp. Epidemiologia zespołu metabolicznego w Polsce. Wyniki programu WOBASZ. Kardiol Pol 2005; 63 (supl. 4): S1-S4.
24. Kono M., Tatsumi K., Saibara T. i wsp. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007; 131: 1387-1392.
25. Ford E.S. Prevalence of metabolic syndrome defined by International Diabetes Federation among adults in the US. Diabetes Care 2005; 28: 2745-2749.
26. Athyros V.G., Ganotakis E.S., Elisaf M., Mikhailidis D.P. The prevalence of the metabolic syndrome using the National Cholesterol Education Program and International Diabetes Federation definition. Curr. Med. Res. Opin. 2005; 25: 1157-1159.
27. Mancia G., Bombelli M., Facchetti i wsp. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events. J. Hypert. 2010; 28: 999-1006.
28. Grandi A.G., Laurita E., Marchesi Ch. i wsp. OSA, metabolic syndrome and CPAP: effect on cardiac remodeling in subjects with abdominal obesity. Respir. Med. 2012; 106: 145-152.
29. Bonsignore M.R., Esquinas C., Barcelo A. i wsp. Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur. Respir. J. 2012; 39: 1136-1143.